
Electra Therapeutics
Operator of a biotechnology company intended for the treatment of immunological diseases and cancer. The company's lead product is a monoclonal antibody that targets a signal regulatory protein on the...
Valuation
$479M
Latest known
Share Price
N/A
Total Raised
$301M
Last Round
N/A